Particle.news

Download on the App Store

Neuralink Trial Enables Quadriplegic to Write Name by Thought

The milestone validates telepathic computer control, ushering in broader trial enrollment.

Overview

  • Audrey Crews, identified as patient P9, used her Neuralink implant to type her name purely through thought for the first time in 20 years.
  • The coin-sized N1 device was implanted under her skull with 128 ultra-thin threads in her motor cortex to detect neural signals and transmit them wirelessly.
  • Neuralink achieved its first same-day dual implant surgeries by placing chips in both P8 and P9 during a single clinical session.
  • Crews emphasized that the implant enables digital interaction only and does not restore muscle movement or walking ability.
  • Neuralink is expanding its PRIME human trial, refining implant performance and moving toward a 2030 commercial launch of its Blindsight vision-restoring chip.